Insulin Drip to Subcutaneous Transition Calculator
Estimate the starting subcutaneous TDD when transitioning a patient from IV insulin infusion to a basal-bolus regimen. Based on the infusion rate averaged over the prior 6–8 hours. Clinical supervision required.
🔁 IV → SubQ Transition Estimator
Subcutaneous Starting Regimen Estimate
(50% of TDD)
(50% of TDD)
(÷ 3 meals)
units/day
Transition Protocol Overview
Standard IV → SubQ Steps
- Calculate IV TDD: average rate (units/hr) × 24
- Apply reduction factor (typically 70–80% of IV TDD)
- Split into 50% basal (long-acting) + 50% bolus (rapid-acting)
- Give first long-acting dose 1–2 hours before stopping IV infusion
- Divide bolus pool across meals (3 equal doses as starting point)
- Monitor closely for 24–48 hours after transition
Overlap the injections. Long-acting insulin takes 1–4 hours to reach meaningful activity. If the IV is stopped simultaneously with the first basal injection, a dangerous hyperglycemic gap can occur. Always administer the first basal dose while the IV is still running, then stop the IV 1–2 hours later per institutional protocol.
Why the timing of the switch matters
Intravenous insulin clears the bloodstream within minutes of the drip being switched off. Subcutaneous insulin, by contrast, takes time to absorb and start working — long-acting insulin may need an hour or two to kick in. If you simply stop the infusion and give the first injection at the same moment, you create an uncovered gap where no effective insulin is present, and glucose can rebound sharply. In ketoacidosis, that gap can even let ketones return.
The fix is overlap. The first dose of long-acting subcutaneous insulin is given before the drip is stopped — commonly one to two hours ahead — so the new insulin is already active when the infusion ends. Getting this hand-off right is the single most important safety step in the transition.
How the subcutaneous dose is estimated from the drip
The patient's recent infusion rate is the best clue to their true daily insulin requirement, because it reflects what actually controlled their glucose. A common approach is to take the average hourly rate over the last stable several hours, project it across 24 hours to estimate the total daily dose, and then deliberately give only a portion of that — often around 75–80% — as the new subcutaneous regimen.
Why clinicians use only part of the calculated dose
Scaling back provides a safety margin. Stress, illness, and IV dextrose can all inflate the drip requirement, so the full projected dose may be more than the patient needs once they're recovering and eating. Starting slightly conservative and adjusting upward is far safer than overshooting into hypoglycemia.
Avoiding rebound high blood sugar after the switch
Even with good timing and dosing, glucose needs close monitoring for the first day after the transition. Frequent checks catch an early rebound while it's still easy to correct, and they confirm the new basal and mealtime doses are holding. This whole process is an inpatient, clinician-led procedure — the numbers here are an educational illustration of the principles, not a protocol to follow on your own.
Frequently Asked Questions
How do you convert an IV insulin drip to subcutaneous insulin?
Estimate the 24-hour IV requirement from a stable infusion period, multiply by a reduction factor of about 70–80%, then split the result roughly 50% basal (long-acting) and 50% bolus (rapid-acting) divided across meals.
Why multiply by 70–80% instead of the full IV dose?
IV requirements often reflect acute stress, and subcutaneous insulin has different pharmacokinetics. Applying a reduction factor (commonly 80%) lowers the risk of hypoglycemia as the patient stabilizes. The exact factor is set by clinical judgment and protocol.
When should the first long-acting dose be given?
Give the first basal (long-acting) injection 1–2 hours before stopping the IV infusion. Long-acting insulin needs 1–4 hours to take effect, so overlapping prevents a hyperglycemic gap when the drip is discontinued.
Is this transition done at home?
No. The IV-to-subcutaneous transition happens in the hospital under a protocol with close glucose monitoring for 24–48 hours. This calculator is an educational reference for clinicians and students.
Sources
- ADA/AACE Inpatient Glycemic Control Consensus Statement. Diabetes Care. 2009.
- Umpierrez GE et al. "Management of Hyperglycemia in Hospitalized Patients." J Clin Endocrinol Metab. 2012.
Last reviewed: June 2025